Patents by Inventor Ronan DEPOORTERE

Ronan DEPOORTERE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9687459
    Abstract: The present inventions concerns derivatives of aminocyclobutane, particularly as NMDA receptor antagonists, their application in human therapy and their method of preparation. These compounds correspond to the general formula (1): wherein: X1 represents a hydrogen atom or fluorine atom; X2 is a hydrogen atom or fluorine atom or chlorine atom; R1 represents a hydrogen atom or fluorine atom or chlorine atom or methyl group or methoxy group or cyano group; R2 represents independently or together a methyl group or ethyl group.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: June 27, 2017
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Bernard Vacher, Elodie Blanc, Ronan Depoortere
  • Publication number: 20170065543
    Abstract: The present inventions concerns derivatives of aminocyclobutane, particularly as NMDA receptor antagonists, their application in human therapy and their method of preparation. These compounds correspond to the general formula (1): wherein: X1 represents a hydrogen atom or fluorine atom; X2 is a hydrogen atom or fluorine atom or chlorine atom; R1 represents a hydrogen atom or fluorine atom or chlorine atom or methyl group or methoxy group or cyano group; R2 represents independently or together a methyl group or ethyl group.
    Type: Application
    Filed: September 12, 2016
    Publication date: March 9, 2017
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Bernard VACHER, Elodie BLANC, Ronan DEPOORTERE
  • Patent number: 9469601
    Abstract: The present inventions concerns derivatives of aminocyclobutane, particularly as NMDA receptor antagonists, their application in human therapy and their method of preparation. These compounds correspond to the general formula (1): wherein: X1 represents a hydrogen atom or fluorine atom; X2 is a hydrogen atom or fluorine atom or chlorine atom; R1 represents a hydrogen atom or fluorine atom or chlorine atom or methyl group or methoxy group or cyano group; R2 represents independently or together a methyl group or ethyl group.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: October 18, 2016
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Bernard Vacher, Elodie Blanc, Ronan Depoortere
  • Publication number: 20150315132
    Abstract: The present inventions concerns derivatives of aminocyclobutane, particularly as NMDA receptor antagonists, their application in human therapy and their method of preparation. These compounds correspond to the general formula (1): wherein: X1 represents a hydrogen atom or fluorine atom; X2 is a hydrogen atom or fluorine atom or chlorine atom; R1 represents a hydrogen atom or fluorine atom or chlorine atom or methyl group or methoxy group or cyano group; R2 represents independently or together a methyl group or ethyl group.
    Type: Application
    Filed: December 4, 2013
    Publication date: November 5, 2015
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Bernard VACHER, Elodie BLANC, Ronan DEPOORTERE